Advanced Blood Sugar Monitoring - Basic Plus

The Advanced Blood Sugar Monitoring - Basic Plus panel contains 4 tests with 10 biomarkers.

Brief Description: The Advanced Blood Sugar Monitoring - Basic Plus panel offers a more detailed look into blood sugar regulation and potential autoimmune aspects of diabetes. It includes the 3 Specimens Glucose Tolerance Test, Glutamic Acid Decarboxylase-65 Antibody, Hemoglobin A1c, and 3 Specimens Insulin Response to Glucose, providing a comprehensive evaluation of glucose metabolism and insulin function.

Collection Method: Blood Draw

Specimen Type: Whole Blood, Plasma, and Serum

Test Preparation: Overnight fasting required. No food or beverage other than water for at least 8 hours before specimen collection.

High carbohydrate diet for 3 days before specimen collection

When and Why the Advanced Blood Sugar Monitoring - Basic Plus Panel May Be Ordered

This panel is typically ordered for individuals showing signs of glucose intolerance, those at risk of diabetes, particularly Type 1 diabetes, or for those with a family history of autoimmune diabetes. It's also useful for monitoring individuals with a known diagnosis of diabetes who require detailed monitoring of their insulin response and glucose handling over time.

What the Advanced Blood Sugar Monitoring - Basic Plus Panel Checks For

  • 3 Specimens Glucose Tolerance Test: Measures the body's ability to metabolize glucose over a set period, identifying potential glucose intolerance or diabetes.

  • Glutamic Acid Decarboxylase-65 Antibody: Tests for antibodies against GAD-65, a marker for autoimmune diabetes, such as Type 1 diabetes, providing insight into the possible autoimmune etiology of diabetes.

  • Hemoglobin A1c: Offers an overview of average blood glucose control over the previous 2-3 months, crucial for long-term diabetes management.

  • 3 Specimens Insulin Response to Glucose: Evaluates how well the body responds to glucose intake by measuring insulin levels at multiple intervals after glucose administration, assessing insulin production and risk for insulin resistance.

Getting a Deeper Understanding of Your Blood Sugar

For an even more comprehensive understanding of blood sugar regulation and diabetes risk, consider the following advanced panels:

  • Advanced Blood Sugar Monitoring - Advanced panel: Adds Adiponectin and an additional specimen to both the glucose tolerance and insulin response tests, enhancing the assessment of metabolic health and insulin sensitivity.

  • Advanced Blood Sugar Monitoring - Comprehensive panel: The most inclusive panel, further including IA-2 Antibody and Proinsulin tests, along with an expanded glucose tolerance test, offering a full spectrum analysis of diabetes risk, autoimmune markers, and insulin precursor levels.

Conditions or Diseases the Advanced Blood Sugar Monitoring - Basic Plus Panel Can Check For

This panel is instrumental in diagnosing and managing diabetes, particularly in distinguishing between Type 1 and Type 2 diabetes, assessing insulin resistance, and monitoring glucose tolerance and insulin sensitivity.

Use of Advanced Blood Sugar Monitoring - Basic Plus Panel Results by Healthcare Professionals

Healthcare professionals use these results to diagnose diabetes, differentiate between Type 1 and Type 2 diabetes, assess the risk of developing diabetes, and tailor treatment plans for managing blood sugar levels, considering both autoimmune components and insulin response.

The Advanced Blood Sugar Monitoring - Basic Plus panel provides a detailed evaluation of an individual's ability to process glucose and produce insulin, along with insights into the autoimmune aspects of diabetes. It's a valuable tool for those at risk of diabetes or with existing diabetes needing closer monitoring. Upgrading to the Advanced or Comprehensive panels offers broader insights into metabolic health, insulin sensitivity, and more precise autoimmune markers, enabling a tailored and proactive approach to diabetes management and prevention.

We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Glucose Tolerance Test 3 Specimens 75g

1 Hour Specimen

2 Hour Specimen

Fasting Specimen

Also known as: Glutamic Acid Decarboxylase65 Antibody

Glutamic Acid

GLUTAMIC ACID

Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c

Hemoglobin A1c

The A1c test evaluates the average amount of glucose in the blood over the last 2 to 3 months. It does this by measuring the concentration of glycated (also often called glycosylated) hemoglobin A1c. Hemoglobin is an oxygen-transporting protein found inside red blood cells (RBCs). There are several types of normal hemoglobin, but the predominant form – about 95-98% – is hemoglobin A. As glucose circulates in the blood, some of it spontaneously binds to hemoglobin A. The hemoglobin molecules with attached glucose are called glycated hemoglobin. The higher the concentration of glucose in the blood, the more glycated hemoglobin is formed. Once the glucose binds to the hemoglobin, it remains there for the life of the red blood cell – normally about 120 days. The predominant form of glycated hemoglobin is referred to as HbA1c or A1c. A1c is produced on a daily basis and slowly cleared from the blood as older RBCs die and younger RBCs (with non-glycated hemoglobin) take their place. This test is used to monitor treatment in someone who has been diagnosed with diabetes. It helps to evaluate how well their glucose levels have been controlled by treatment over time. This test may be used to screen for and diagnose diabetes or risk of developing diabetes. In 2010, clinical practice guidelines from the American Diabetes Association (ADA) stated that A1c may be added to fasting plasma glucose (FPG) and oral glucose tolerance test (OGTT) as an option for diabetes screening and diagnosis. For monitoring purposes, an A1c of less than 7% indicates good glucose control and a lower risk of diabetic complications for the majority of diabetics. However, in 2012, the ADA and the European Association for the Study of Diabetes (EASD) issued a position statement recommending that the management of glucose control in type 2 diabetes be more "patient-centered." Data from recent studies have shown that low blood sugar (hypoglycemia) can cause complications and that people with risk of severe hypoglycemia, underlying health conditions, complications, and a limited life expectancy do not necessarily benefit from having a stringent goal of less than 7% for their A1c. The statement recommends that people work closely with their doctor to select a goal that reflects each person's individual health status and that balances risks and benefits.

Also known as: Insulin Response to Glucose 3 Specimens

Insulin, Specimen 1

Insulin, Specimen 2

Insulin, Specimen 3

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through Quest Diagnostics. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 Quest Diagnostics laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

Customer Reviews